Cross-Sector entity

ResMed

Company RMD
5

ResMed is most often covered alongside Citigroup, which appears in 3 of these 5 stories. That works out to roughly 0.9 stories per week across a 39-day span. The busiest single day carried 3. medical-devices accounts for 2 of the 5 tracked stories, while 3 other categories carry the remainder.

5 verified stories tracked

Last mentioned: Aug 17, 2026

RSS updates
Share

Entity pulse

Recent coverage · ResMed

↑
5 stories
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about ResMed

ResMed is most often covered alongside Citigroup, which appears in 3 of these 5 stories. That works out to roughly 0.9 stories per week across a 39-day span. The busiest single day carried 3. medical-devices accounts for 2 of the 5 tracked stories, while 3 other categories carry the remainder. Negative sentiment appears in 0% of the tracked stories. Each carries 2.2 original sources on average. This profile follows 5 Cross-Sector stories mentioning ResMed across the period from July 10, 2026 to August 17, 2026.

Stories tracked
5
Per week
0.9
Negative
0%
Sources per story
2.2

Computed from the 5 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering ResMed. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. 2026 Annual Meeting of Stockholders

    ResMed holds its annual meeting; Ron Taylor is not standing for reelection and will retire.

  2. Carol Burt becomes Lead Director

    Carol Burt's appointment as ResMed Lead Director takes effect.

  3. ResMed announces leadership transition

    ResMed issues a press release announcing Carol Burt will become Lead Director on November 15, 2026, and Ron Taylor will retire.

  4. Carol Burt joins board; Taylor becomes Lead Director

    Carol Burt joins ResMed's Board of Directors. In the same year, Ron Taylor assumes the role of Lead Director.

  5. Ron Taylor joins ResMed board

    Ron Taylor becomes a member of ResMed's Board of Directors, beginning a tenure that would last more than 21 years.

Stories mentioning ResMed 5

Healthcare medical devices Neutral 5

ResMed Names Carol Burt Lead Director as 21-Year Vet Ron Taylor Retires

ResMed is elevating governance and compliance expertise to its lead director role at a time when AI-enabled sleep and respiratory devices face rising regulatory and data privacy expectations. Carol Burt's appointment and Ron Taylor's retirement signal a deliberate board transition rather than disruption. Health systems, investors, and partners should watch committee assignments and product governance signals through the November 2026 annual meeting.

2 sources

Source: (ca) · GlobeNewswire (CA)